Anthony Centlivre
Psychiatric/Mental Health · Fort Wayne, INNPI 1255051231
Payments from drug & device makers
Across 316 payments — averaging $12.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lundbeck LLC$1K
- Otsuka America Pharmaceutical, Inc.$449
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$418
- AbbVie$405
- Alkermes, Inc.$297
- E.r. Squibb & Sons, L.L.C.$222
- plus $932 from 15 others
What the payments were for
- Food & beverage$3,79898%
- Education$592%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lundbeck LLC | 161 | $1,134 |
| Otsuka America Pharmaceutical, Inc. | 21 | $449 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 26 | $418 |
| AbbVie | 25 | $405 |
| Alkermes, Inc. | 13 | $297 |
| E.r. Squibb & Sons, L.L.C. | 20 | $222 |
| Vanda Pharmaceuticals Inc. | 10 | $143 |
| Teva Pharmaceuticals USA, Inc. | 7 | $138 |
| Novo Nordisk | 1 | $125 |
| Indivior Inc. | 5 | $86 |
| Neurocrine Biosciences, Inc. | 4 | $70 |
| Biogen | 3 | $68 |
| Idorsia Pharmaceuticals US Inc | 3 | $50 |
| Supernus Pharmaceuticals, Inc. | 3 | $50 |
| Johnson & Johnson | 3 | $48 |
| Sunovion Pharmaceuticals Inc. | 3 | $42 |
| Axsome Therapeutics, Inc. | 2 | $35 |
| Ironshore Pharmaceuticals Inc. | 2 | $31 |
| Neos Therapeutics, LP | 1 | $18 |
| Orexo US, Inc. | 1 | $16 |
| Corium, LLC | 2 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,857 in reported general payments places this provider in the 85th percentile of 729 psychiatric/mental health providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RexultiBrexpiprazole | 22 | $30,985 |
| TrintellixVortioxetine Hydrobromide | 21 | $13,141 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 40 | $3,712 |
| Aripiprazole | 20 | $1,346 |
| Lurasidone Hcl | 12 | $1,021 |
| Buspirone Hcl | 79 | $841 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 32 | $821 |
| Oxcarbazepine | 12 | $697 |
| Hydroxyzine Pamoate | 25 | $621 |
| Fluoxetine Hcl | 45 | $550 |
| Duloxetine Hcl | 51 | $499 |
| Trazodone Hcl | 75 | $436 |
| Sertraline Hcl | 61 | $365 |
| Risperidone | 16 | $336 |
| Hydroxyzine Hcl | 22 | $284 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Otsuka America Pharmaceutical, Inc.Rexulti | $449 | $30,98522 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 729 psychiatric/mental health providers in Indiana.
Other psychiatric/mental health in Fort Wayne
- Sharon ClevengerFort Wayne$22K
- Teresa RobertsFort Wayne$13K
- Melodie GavinFort Wayne$9K
- Valerie RumpleFort Wayne$8K
- Sherri AlbertsonFort Wayne$6K
- Brooke KempfTerre Haute$1.1M
- Gerald LewisMerrillville$336K
- Lauren LutzColumbus$320K
- Sonya RuedlingerIndianapolis$134K
- Trina GreenwaldMarion$107K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.